Results 251 to 260 of about 185,596 (291)
Acute circulating tumor DNA dynamics during and after systemic therapy initiation for advanced triple-negative breast cancer. [PDF]
NPJ Breast CancerTo B +8 more
europepmc +1 more source
Systematic review and meta-analysis of studies assessing circulating tumor DNA kinetics in metastatic colorectal cancer. [PDF]
ESMO Gastrointest OncolCallesen LB, Spindler KG.
europepmc +1 more source
Potential of circulating tumor DNA to refine immunotherapy
Cancer, 2023 Circulating tumor DNA (ctDNA) is a noninvasive strategy to disease assessment of minimal residual disease and treatment response for advanced cancer. ctDNA is emerging as a tool for use in clinical practice and informing novel clinical trial designs in melanoma.
Rebecca J. Lee, Jason J. Luke
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Circulating Tumor DNA in Lymphoma
Current Hematologic Malignancy Reports, 2022Recent advances have been made in circulating tumor DNA (ctDNA), the method to minimally invasive detect lymphoma sensitively with tumor-derived DNA in the blood of patients with lymphomas. This article discusses these various methods of ctDNA detection and the clinical context in which they have been applied to for a variety of lymphoma subtypes.ctDNA
Swetha Kambhampati, Thiruvengadam +1 more
openaire +2 more sources
Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers
Urologic Clinics of North America, 2023Liquid biopsies such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have great potential to serve as prognostic and predictive biomarkers in urologic cancers. The possibility of using liquid biopsies for real-time noninvasive and dynamic monitoring of response to therapy has been an active area of investigation.
Ikenna, Madueke +2 more
openaire +2 more sources
Circulating tumor DNA in neuroblastoma
Pediatric Blood & Cancer, 2020AbstractAs a sympathetic nervous system–derived tumor, aggressive neuroblastoma (NB) is currently attracting interest from researchers seeking diagnostic and prognostic markers via less invasive procedures. The analysis of circulating tumor DNA (ctDNA) in peripheral blood can provide genetic information from multiple tumor lesions and is not dependent ...
Meng Wei +3 more
openaire +2 more sources
Circulating tumor DNA analysis for tumor diagnosis
Talanta, 2021Tumor is a kind of abnormal organism generated by the proliferation and differentiation of cells in the body under the action of various initiating and promoting factors, which seriously threatens human life and health. Tumorigenesis is a gradual process that involves multistage reactions and the accumulation of mutations.
Yi-Hui, Wang +3 more
openaire +2 more sources
Circulating Tumor Cells and Circulating Tumor DNA
Annual Review of Medicine, 2012Solid tumors derived from epithelial tissues (carcinomas) are responsible for 90% of all new cancers in Europe, and the main four tumor entities are breast, prostate, lung, and colon cancer. Present tumor staging is mainly based on local tumor extension, metastatic lymph node involvement, and evidence of overt distant metastasis obtained by imaging ...
Catherine, Alix-Panabières +2 more
openaire +2 more sources
Analysis of Circulating Tumor DNA
2018Circulating tumor DNA (ctDNA) analysis is currently gaining momentum as an innovative methodology for characterizing the tumor genome and monitoring therapeutic efficacy in the multifocal, genetically and spatially heterogeneous plasma cell malignancy, multiple myeloma (MM).
Sridurga, Mithraprabhu, Andrew, Spencer
openaire +2 more sources